Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Warning Letters
Manufacturing
Cipla plant slammed with FDA warning letter for ongoing problems
Cipla was slammed with a warning letter that outlined a number of ongoing issues with the company’s manufacturing facility in Pithampur, India.
Joseph Keenan
Nov 27, 2023 10:30am
FDA slams Natco Pharma with Form 483 over sanitary, other issues
Nov 6, 2023 10:35am
FDA slams Ali Pharma with warning over porcine API production
Nov 1, 2023 9:05am
FDA hits Swiss UCB facility with Form 483, cites records issues
Oct 26, 2023 8:20am
FDA slams Ohio drug repackager with warning letter
Sep 13, 2023 9:20am
FDA again slams Biocon's troubled plant in Malaysia
Aug 17, 2023 8:41am
